| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,379 |
30,517 |
$2.75M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,003 |
31,737 |
$2.69M |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,669 |
11,164 |
$195K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,307 |
6,029 |
$172K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,564 |
1,537 |
$126K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,513 |
1,509 |
$115K |
| 99215 |
Prolong outpt/office vis |
1,457 |
1,244 |
$94K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,184 |
1,162 |
$93K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,325 |
1,321 |
$90K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,303 |
1,276 |
$89K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,034 |
3,716 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
462 |
461 |
$43K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
349 |
347 |
$33K |
| 87254 |
|
3,061 |
2,934 |
$32K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,721 |
1,703 |
$30K |
| 87430 |
|
3,073 |
2,938 |
$28K |
| 90461 |
|
1,513 |
1,508 |
$25K |
| 81002 |
|
1,994 |
1,917 |
$22K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,311 |
2,293 |
$22K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
130 |
127 |
$15K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
382 |
353 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,555 |
1,481 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
118 |
117 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
567 |
528 |
$10K |
| 81003 |
|
1,283 |
1,248 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
784 |
723 |
$9K |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
206 |
189 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
131 |
129 |
$7K |
| 81025 |
|
405 |
397 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
457 |
435 |
$6K |
| 85018 |
|
229 |
229 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,035 |
997 |
$2K |
| 99385 |
|
12 |
12 |
$2K |
| 99381 |
|
25 |
24 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
268 |
265 |
$2K |
| 87807 |
|
90 |
90 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
24 |
24 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
88 |
87 |
$929.84 |
| 82962 |
|
74 |
68 |
$373.92 |
| 99173 |
|
91 |
90 |
$226.75 |
| 90715 |
|
13 |
13 |
$192.81 |
| 96127 |
|
38 |
38 |
$160.17 |
| 90658 |
|
75 |
75 |
$128.37 |
| 90670 |
|
225 |
225 |
$96.29 |
| 94664 |
|
12 |
12 |
$83.62 |
| 99406 |
|
29 |
26 |
$33.10 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
30 |
30 |
$29.24 |
| 90633 |
|
25 |
25 |
$0.03 |
| 90648 |
|
73 |
73 |
$0.01 |
| 90651 |
|
12 |
12 |
$0.00 |
| 90756 |
|
70 |
69 |
$0.00 |